SAN DIEGO, Oct. 2, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq:KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its President and CEO, Robert E. Hoffman will present in the LD Micro Main Event XVI Conference on Wednesday, October 4, 2023 at 11:30 am PT at the Luxe Sunset Boulevard Hotel in Los Angeles, California.
Read more at prnewswire.comKintara Therapeutics to Present at the LD Micro Main Event XVI Conference
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/AI%20(artificial%20intelligence)/Artificial%20intelligence%20and%20machine%20learning%20concept%20-%20by%20amgun%20via%20iStock.jpg)
/Broadcom%20Inc%20logo%20on%20building-by%20Poetra_%20RH%20via%20Shutterstock.jpg)
/Oracle%20Corp_%20logo%20on%20phone-by%20WonderPix%20via%20Shutterstock.jpg)
